D68.32 - Hemorrhagic disorder due to extrinsic circulating anticoagulants
- Applicable to Hemorrhagic disorder due to extrinsic circulating anticoagulants
- The 2025 edition of ICD10-CM D68.32 became effective on October 1, 2024.
- This is the American ICD10-CM version of D68.32 - other international versions of ICD10 D68.32 may differ.
- D68.32 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Code Additional Code
- code for adverse effect, if applicable, to identify drug (T45.515, T45.525)
Inclusion Term
- Drug-induced hemorrhagic disorder
- Hemorrhagic disorder due to increase in anti-IIa
- Hemorrhagic disorder due to increase in anti-Xa
- Hyperheparinemia
The following codes above D68.32 contain annotation back-references that may be applicable to D68.32:
Section: D65-D69 Coagulation defects, purpura and other hemorrhagic conditions
Category: D68 Other coagulation defects
Billable/Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com